 Advertisement | ||||||||
 | ||||||||
|
||||||||
 |
 |
 |
 |
 |
 |
 |
||
|
From the Comprehensive Pain Program, Toronto Western Hospital (Furlan, Sandoval, Mailis-Gagnon); University of Toronto Centre for the Study of Pain (Furlan, Mailis-Gagnon); Institute for Work & Health (Furlan); Health Policy Management and Evaluation, University of Toronto (Furlan); Krembil Neuroscience Center, Toronto Western Hospital (Mailis-Gagnon), Toronto; Chedoke Rehabilitation Center, Hamilton Health Sciences Hospitals, McMaster University (Tunks), Hamilton, Ont.
Correspondence to: Dr. Angela Mailis-Gagnon, Medical Director, Comprehensive Pain Program, Toronto Western Hospital, 399 Bathurst St., Rm. 4F811, Toronto ON M5T 2S8; fax 416 603-5725; angela.mailis{at}uhn.on.ca
Abstract
Background: Chronic noncancer pain (CNCP) is a major health problem, for which opioids provide one treatment option. However, evidence is needed about side effects, efficacy, and risk of misuse or addiction.
Methods: This meta-analysis was carried out with these objectives: to compare the efficacy of opioids for CNCP with other drugs and placebo; to identify types of CNCP that respond better to opioids; and to determine the most common side effects of opioids. We searched MEDLINE, EMBASE, CENTRAL (up to May 2005) and reference lists for randomized controlled trials of any opioid administered by oral or transdermal routes or rectal suppositories for CNCP (defined as pain for longer than 6 mo). Extracted outcomes included pain, function or side effects. Methodological quality was assessed with the Jadad instrument; analyses were conducted with Revman 4.2.7.
Results: Included were 41 randomized trials involving 6019 patients: 80% of the patients had nociceptive pain (osteoarthritis, rheumatoid arthritis or back pain); 12%, neuropathic pain (postherpetic neuralgia, diabetic neuropathy or phantom limb pain); 7%, fibromyalgia; and 1%, mixed pain. The methodological quality of 87% of the studies was high. The opioids studied were classified as weak (tramadol, propoxyphene, codeine) or strong (morphine, oxycodone). Average duration of treatment was 5 (range 1–16) weeks. Dropout rates averaged 33% in the opioid groups and 38% in the placebo groups. Opioids were more effective than placebo for both pain and functional outcomes in patients with nociceptive or neuropathic pain or fibromyalgia. Strong, but not weak, opioids were significantly superior to naproxen and nortriptyline, and only for pain relief. Among the side effects of opioids, only constipation and nausea were clinically and statistically significant.
Interpretation: Weak and strong opioids outperformed placebo for pain and function in all types of CNCP. Other drugs produced better functional outcomes than opioids, whereas for pain relief they were outperformed only by strong opioids. Despite the relative shortness of the trials, more than one-third of the participants abandoned treatment.
This article has been cited by other articles:
|
|
 |
|
  J. M. Thompson, R. Chiasson, P. Loisel, L. C. M. Besemann, and T. Pranger La douleur d'un marina: Troubles musculosquelettiques, douleur chronique et invalidite chez les veterans militaires Can Fam Physician, November 1, 2009; 55(11): e50 - e54. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thompson, R. Chiasson, P. Loisel, L. C. M. Besemann, and T. Pranger A sailor's pain: Veterans' musculoskeletal disorders, chronic pain, and disability Can Fam Physician, November 1, 2009; 55(11): 1085 - 1088. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Argoff and D. I. Silvershein A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs Mayo Clin. Proc., July 1, 2009; 84(7): 602 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Rittner, A. Brack, and C. Stein Pain and the immune system Br. J. Anaesth., July 1, 2008; 101(1): 40 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Rathmell A 50-Year-Old Man With Chronic Low Back Pain JAMA, May 7, 2008; 299(17): 2066 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Lorenz, J. Lynn, S. M. Dy, L. R. Shugarman, A. Wilkinson, R. A. Mularski, S. C. Morton, R. G. Hughes, L. K. Hilton, M. Maglione, et al. Evidence for Improving Palliative Care at the End of Life: A Systematic Review Ann Intern Med, January 15, 2008; 148(2): 147 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chou, A. Qaseem, V. Snow, D. Casey, J. T. Cross Jr, P. Shekelle, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society Ann Intern Med, October 2, 2007; 147(7): 478 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chou and L. H. Huffman Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline Ann Intern Med, October 2, 2007; 147(7): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Furlan, A. Mailis-Gagnon, and E. Tunks Fundamental problem with opioid trials for chronic pain Can. Med. Assoc. J., April 24, 2007; 176(9): 1308 - 1308. [Full Text] [PDF]
|
|
|
|
|
|
T. Mehta Fundamental problem with opioid trials for chronic pain Can. Med. Assoc. J., April 24, 2007; 176(9): 1307 - 1308. [Full Text] [PDF]
|
|
|
|
|
|
B. Berman A 60-Year-Old Woman Considering Acupuncture for Knee Pain JAMA, April 18, 2007; 297(15): 1697 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Morice, M. S. Menon, S. A. Mulrennan, C. F. Everett, C. Wright, J. Jackson, and R. Thompson Opiate Therapy in Chronic Cough Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 312 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., December 1, 2006; 11(6): 190 - 190. [Full Text] [PDF]
|
|
Read all eLetters
| HOME | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | HELP | SEARCH |
|
|||||
|
Copyright 1995-2006, Canadian Medical Association. All rights reserved. ISSN 1488-2329
(e) 0820-3946 (p)
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association. |
|||||
